Rexulti (brexpiprazole) is a prescription antipsychotic medication used in the treatment of major depressive disorder, schizophrenia in adults and children aged 13 years and older, and agitation associated with dementia due to Alzheimer’s disease....
在欧洲,brexpiprazole(品牌名:Rxulti)于2018年7月底获批,治疗精神分裂症成人患者。 精神分裂症(schizophrenia)是一种慢性、严重的精神健康障碍,往往致残;患者可能出现认知、情绪、行为方面的改变,其中妄想和幻觉是最常见的症状。精神分裂症的病程一般迁延,呈反复发作、加重或恶化,部分患者最终出现衰退和精神残疾,但有的患...
Recommended Dosage for Schizophrenia (Adults and Pediatric Patients 13 to 17 Years) Adults The recommended starting Rexulti dosage for thetreatment of schizophrenia in adults is 1 mg once daily on Days 1 to 4. Titrate to 2 mg once daily on Day 5 through Day 7. On Day 8, the dosage can ...
在欧洲,brexpiprazole(品牌名:Rxulti)于2018年7月底获批,治疗精神分裂症成人患者。 精神分裂症(schizophrenia)是一种慢性、严重的精神健康障碍,往往致残;患者可能出现认知、情绪、行为方面的改变,其中妄想和幻觉是最常见的症状。精神分裂症的病程一般迁延,呈反复发作、加重或恶化,部分患者最终出现衰退和精神残疾,但有的患...
精神分裂症(schizophrenia)是一种慢性、严重的精神健康障碍,往往致残;患者可能出现认知、情绪、行为方面的改变,其中妄想和幻觉是最常见的症状。精神分裂症的病程一般迁延,呈反复发作、加重或恶化,部分患者最终出现衰退和精神残疾,但有的患者经过治疗后可保持痊愈或基本痊愈状态。
Overdose/Missed Dose Reviews (113) Uses What is Rexulti used for? Rexulti (brexpiprazole) is commonly used to treat people withdepression,schizophrenia, or agitation due to dementia withAlzheimer’s disease. Rexulti may also be used for other conditions as determined by your healthcare provider. ...
(2.1, 2.2, 12.3) Indication Starting Dose Recommended Dose Maximum Dose MDD Adults (2.1) 0.5 mg/day or 1 mg/day 2 mg/day 3 mg/day Schizophrenia Adults (2.2) 1 mg/day 2 to 4 mg/day 4 mg/day Schizophrenia Pediatric (13 - 17 years) (2.2) 0.5 mg/day 2 to 4 mg/day 4 mg/day...
Your doctor or pharmacist will review your medicines for drug interactions while you are taking Rexulti. Bottom Line Rexulti (generic name: brexpiprazole) is an atypical antipsychotic used to treat patients with schizophrenia, depression or agitation associated with dementia due to Alzheimer’s disease....
adults. Brexpiprazole was also approved by Health Canada for schizophrenia and adjunctive treatment of MDD in 2017 and 2019, respectively. It was approved by the Ministry of Health, Labour and Welfare in Japan and by the Europe...
patients with dementia-related psychosis treated dose reduction or discontinuation. (5.7) with antipsychotic drugs are at increased risk of death. 下载文档 收藏 分享赏 0 内容提供方:千年硕鼠 审核时间:2023-05-16 审核编号:8130062037005067 认证类型:实名认证...